Status and phase
Conditions
Treatments
About
The main objective of the PROOF trial is to investigate efficacy and safety of normobaric hyperoxygenation (NBHO) as a neuroprotective treatment in patients with acute ischemic stroke due to large vessel occlusion likely to receive endovascular mechanical thrombectomy (TBY) in a randomized controlled clinical phase IIb trial.
Full description
http://www.proof-trial.eu/
European Union's Horizon 2020 research and innovation programme grant 733379 (2016): Euro 5.8 Mio
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria
Exclusion Criteria
Neurological:
Respiratory:
Other:
Primary purpose
Allocation
Interventional model
Masking
223 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal